Avecho Biotechnology Ltd has released a press release.
June 2022 Quarterly Activities Report & Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Story so far
Earlier from Avecho Biotechnology
- Security Class Reinstatement to Quotation- AVEO
- Update on Listed Options and Federal Court Application
- Suspension from Official Quotation - AVEO
- March 2022 Quarterly Activities Report & Appendix 4C
- Positive results from AVEs topical CBD pain study
Later from Avecho Biotechnology
- Increased CBD absorption in dogs vs commercial comparator
- September 2022 Quarterly Activities Report & Appendix 4C
- AVE signs development agreement with Perrigo
- Avecho receives ethics approval for Phase III CBD trial
- Athenex submits Avechos phytonadione to FDA pre-IND
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology